Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
PHG 
Koninklijke Philips NV ADR (PHG)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: PHG (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $33.33
1 Year Target Price $33.33
| 1 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 1.44% | Avg. Invested days 38 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/17/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 27.11B USD | Price to earnings Ratio 150.11 | 1Y Target Price 33.33 |
Price to earnings Ratio 150.11 | 1Y Target Price 33.33 | ||
Volume (30-day avg) 3 | Beta 0.84 | 52 Weeks Range 20.65 - 31.00 | Updated Date 10/19/2025 |
52 Weeks Range 20.65 - 31.00 | Updated Date 10/19/2025 | ||
Dividends yield (FY) 3.39% | Basic EPS (TTM) 0.19 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.91% | Operating Margin (TTM) 9.24% |
Management Effectiveness
Return on Assets (TTM) 2.37% | Return on Equity (TTM) 1.51% |
Valuation
Trailing PE 150.11 | Forward PE 14.51 | Enterprise Value 34089723643 | Price to Sales(TTM) 1.52 |
Enterprise Value 34089723643 | Price to Sales(TTM) 1.52 | ||
Enterprise Value to Revenue 1.63 | Enterprise Value to EBITDA 12.05 | Shares Outstanding 950574479 | Shares Floating 767446306 |
Shares Outstanding 950574479 | Shares Floating 767446306 | ||
Percent Insiders - | Percent Institutions 5.34 |
Upturn AI SWOT
Koninklijke Philips NV ADR
Company Overview
History and Background
Koninklijke Philips NV ADR, founded in 1891 in Eindhoven, Netherlands, initially focused on manufacturing light bulbs. Over time, it diversified into electronics, healthcare, and consumer products. Significant milestones include introducing the first Philips shaver and expanding into medical imaging technologies.
Core Business Areas
- Diagnosis & Treatment: Offers diagnostic imaging systems (MRI, CT, X-ray), image-guided therapy solutions, and ultrasound devices.
- Connected Care: Provides patient monitoring solutions, hospital respiratory care, and sleep and respiratory care devices for home use.
- Personal Health: Focuses on consumer health products such as electric toothbrushes, shavers, and mother and child care products.
Leadership and Structure
The leadership team is headed by CEO Roy Jakobs. The organizational structure includes business segments focusing on Diagnosis & Treatment, Connected Care, and Personal Health, supported by central functions like technology, operations, and finance.
Top Products and Market Share
Key Offerings
- MRI Systems: Magnetic Resonance Imaging systems used for medical diagnostics. Philips is a leading provider in this market. Competitors include Siemens Healthineers and GE Healthcare. Market share is estimated around 25% to 30% globally.
- Electric Toothbrushes: Philips Sonicare range of electric toothbrushes. Market share is significant in the premium segment, competing with Oral-B (Procter & Gamble). They hold around 20% market share globally.
- Patient Monitoring Solutions: Devices and software used to monitor patients' vital signs in hospitals and other healthcare settings. Competitors include Masimo and Medtronic. Revenue figures are substantial but market share is variable depending on the specific product category.
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing growth due to aging populations, increased prevalence of chronic diseases, and technological advancements. The consumer health market is also expanding, driven by a growing focus on preventative care and wellness.
Positioning
Philips is a diversified technology company with a strong presence in healthcare and consumer products. Its competitive advantages include its brand reputation, technological expertise, and global distribution network.
Total Addressable Market (TAM)
The total addressable market for Philips' core segments exceeds $300 billion. Philips is positioned to capture a significant portion of this TAM through innovation, strategic acquisitions, and expansion into emerging markets.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Diversified product portfolio
- Global presence
- Technological expertise
- Innovation capabilities
Weaknesses
- Complex organizational structure
- Exposure to regulatory risks
- Dependence on healthcare spending
- Supply chain vulnerabilities
- Inconsistent profitability
Opportunities
- Growing demand for healthcare technology
- Expansion into emerging markets
- Increased adoption of telehealth
- Development of personalized healthcare solutions
- Strategic acquisitions and partnerships
Threats
- Intense competition
- Technological obsolescence
- Economic downturns
- Changes in government regulations
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- GE
- SIEMENSN.DE
- JNJ
Competitive Landscape
Philips faces intense competition from established players like GE and Siemens, as well as emerging companies specializing in specific healthcare technologies. Philips' strengths lie in its brand reputation and diversified portfolio, while its weaknesses include its complex organizational structure and exposure to regulatory risks.
Major Acquisitions
Spectranetics
- Year: 2017
- Acquisition Price (USD millions): 2200
- Strategic Rationale: Expanded Philips' image-guided therapy portfolio with devices for peripheral vascular interventions.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends will require updated information from public sources.
Future Projections: Future projections will require updated information from public sources.
Recent Initiatives: Recent strategic initiatives of Philips have focused on streamlining operations, divesting non-core assets, and investing in high-growth areas like healthcare technology.
Summary
Koninklijke Philips NV ADR is a diversified technology company with a strong presence in healthcare and consumer products. It has a solid brand and global reach, but it faces challenges from intense competition and complex operations. While innovation and strategic acquisitions are driving growth, effective cost management and navigating regulatory landscapes are critical for sustained success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Reports
- Market Research Reports
Disclaimers:
The analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance can change rapidly, and investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Koninklijke Philips NV ADR
Exchange NYSE | Headquaters - | ||
IPO Launch date 1987-12-30 | President, CEO & Chairman of the Board of Management Mr. Roy Jakobs | ||
Sector Healthcare | Industry Medical Devices | Full time employees 67263 | Website https://www.philips.com |
Full time employees 67263 | Website https://www.philips.com | ||
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.